Group One Trading’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,000
| Closed | -$425K | – | 8350 |
|
|
2025
Q4 | $425K | Buy |
3,000
+1,300
| +76% | +$188K | ﹤0.01% | 3678 |
|
|
2025
Q3 | $239K | Sell |
1,700
-3,400
| -67% | -$461K | ﹤0.01% | 4490 |
|
|
2025
Q2 | $641K | Sell |
5,100
-15,800
| -76% | -$1.81M | ﹤0.01% | 3179 |
|
|
2025
Q1 | $2.31M | Buy |
20,900
+15,500
| +287% | +$1.96M | 0.01% | 1694 |
|
|
2024
Q4 | $737K | Sell |
5,400
-2,600
| -33% | -$322K | ﹤0.01% | 2850 |
|
|
2024
Q3 | $922K | Sell |
8,000
-600
| -7% | -$82.3K | ﹤0.01% | 2369 |
|
|
2024
Q2 | $1.18M | Sell |
8,600
-34,500
| -80% | -$4.73M | ﹤0.01% | 1854 |
|
|
2024
Q1 | $5.94M | Buy |
43,100
+20,800
| +93% | +$2.84M | 0.02% | 726 |
|
|
2023
Q4 | $2.94M | Sell |
22,300
-13,600
| -38% | -$1.57M | 0.01% | 1541 |
|
|
2023
Q3 | $4.04M | Buy |
35,900
+4,600
| +15% | +$484K | 0.01% | 1080 |
|
|
2023
Q2 | $2.95M | Buy |
31,300
+3,000
| +11% | +$293K | 0.01% | 1375 |
|
|
2023
Q1 | $2.86M | Sell |
28,300
-71,400
| -72% | -$7.43M | 0.01% | 1235 |
|
|
2022
Q4 | $11.9M | Buy |
99,700
+78,000
| +359% | +$9.14M | 0.03% | 635 |
|
|
2022
Q3 | $2.31M | Sell |
21,700
-15,200
| -41% | -$1.54M | ﹤0.01% | 1788 |
|
|
2022
Q2 | $3.6M | Buy |
36,900
+7,700
| +26% | +$711K | 0.01% | 1550 |
|
|
2022
Q1 | $2.74M | Buy |
29,200
+700
| +2% | +$59.3K | ﹤0.01% | 2086 |
|
|
2021
Q4 | $2.43M | Buy |
28,500
+16,800
| +144% | +$1.55M | ﹤0.01% | 2383 |
|
|
2021
Q3 | $1.12M | Sell |
11,700
-19,400
| -62% | -$1.83M | ﹤0.01% | 3286 |
|
|
2021
Q2 | $3.03M | Sell |
31,100
-19,500
| -39% | -$1.87M | ﹤0.01% | 2214 |
|
|
2021
Q1 | $4.92M | Buy |
50,600
+19,300
| +62% | +$2.02M | 0.01% | 1527 |
|
|
2020
Q4 | $3M | Buy |
31,300
+17,400
| +125% | +$1.68M | 0.01% | 1701 |
|
|
2020
Q3 | $1.34M | Buy |
13,900
+8,800
| +173% | +$1.02M | ﹤0.01% | 1929 |
|
|
2020
Q2 | $622K | Sell |
5,100
-13,500
| -73% | -$1.49M | ﹤0.01% | 2452 |
|
|
2020
Q1 | $1.61M | Sell |
18,600
-19,700
| -51% | -$1.93M | 0.01% | 1185 |
|
|
2019
Q4 | $4.12M | Buy |
38,300
+31,300
| +447% | +$3.28M | 0.03% | 793 |
|
|
2019
Q3 | $631K | Buy |
7,000
+3,200
| +84% | +$299K | 0.01% | 2133 |
|
|
2019
Q2 | $321K | Sell |
3,800
-4,800
| -56% | -$394K | ﹤0.01% | 2521 |
|
|
2019
Q1 | $758K | Sell |
8,600
-3,900
| -31% | -$326K | 0.01% | 1612 |
|
|
2018
Q4 | $893K | Buy |
12,500
+11,300
| +942% | +$1.08M | 0.01% | 1588 |
|
|
2018
Q3 | $148K | Sell |
1,200
-61,300
| -98% | -$6.96M | ﹤0.01% | 3234 |
|
|
2018
Q2 | $6.14M | Buy |
62,500
+34,200
| +121% | +$3.06M | 0.05% | 443 |
|
|
2018
Q1 | $2.35M | Buy |
28,300
+8,300
| +42% | +$701K | 0.02% | 905 |
|
|
2017
Q4 | $1.55M | Buy |
20,000
+18,800
| +1,567% | +$1.28M | 0.01% | 1356 |
|
|
2017
Q3 | $74K | Sell |
1,200
-31,700
| -96% | -$1.67M | ﹤0.01% | 3415 |
|
|
2017
Q2 | $1.51M | Buy |
32,900
+10,500
| +47% | +$509K | 0.02% | 1146 |
|
|
2017
Q1 | $970K | Buy |
22,400
+3,300
| +17% | +$141K | 0.01% | 1353 |
|
|
2016
Q4 | $739K | Sell |
19,100
-118,000
| -86% | -$5.34M | 0.01% | 1519 |
|
|
2016
Q3 | $6.94M | Sell |
137,100
-25,400
| -16% | -$1.26M | 0.08% | 287 |
|
|
2016
Q2 | $7.39M | Buy |
162,500
+132,800
| +447% | +$6.11M | 0.09% | 248 |
|
|
2016
Q1 | $1.18M | Sell |
29,700
-40,600
| -58% | -$1.61M | 0.02% | 1070 |
|
|
2015
Q4 | $3.98M | Sell |
70,300
-13,100
| -16% | -$666K | 0.05% | 469 |
|
|
2015
Q3 | $3.32M | Buy |
83,400
+25,500
| +44% | +$1.23M | 0.05% | 524 |
|
|
2015
Q2 | $2.77M | Sell |
57,900
-11,000
| -16% | -$466K | 0.04% | 566 |
|
|
2015
Q1 | $2.74M | Sell |
68,900
-29,400
| -30% | -$1.05M | 0.04% | 489 |
|
|
2014
Q4 | $2.2M | Buy |
98,300
+54,400
| +124% | +$1.03M | 0.03% | 601 |
|
|
2014
Q3 | $688K | Sell |
43,900
-38,400
| -47% | -$574K | 0.01% | 1370 |
|
|
2014
Q2 | $1.22M | Buy |
82,300
+44,900
| +120% | +$634K | 0.02% | 1000 |
|
|
2014
Q1 | $602K | Buy |
37,400
+2,100
| +6% | +$35.9K | 0.01% | 1500 |
|
|
2013
Q4 | $330K | Sell |
35,300
-16,700
| -32% | -$163K | 0.01% | 1991 |
|
|
2013
Q3 | $589K | Sell |
52,000
-16,700
| -24% | -$230K | 0.01% | 1471 |
|
|
2013
Q2 | $919K | Buy |
+68,700
| New | +$844K | 0.02% | 881 |
|
Other funds holding NBIX
VPM
VCM
Group One Trading's NBIX Position: Q1 2026 in Review
Group One Trading reduced its Neurocrine Biosciences (NBIX) stake by 24% in Q1 2026, selling an estimated $41.9K and leaving 1,014 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #4463.
Group One Trading first reported a position in NBIX in Q2 2013 and has held it in 26 quarters since. The position peaked at $4.83M in Q1 2022. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.
- Group One Trading held 1,014 shares of Neurocrine Biosciences worth $134K as of Q1 2026.
- Group One Trading sold 316 Neurocrine Biosciences shares in Q1 2026, an estimated $41.9K.
- Neurocrine Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4463 holding.
- Group One Trading first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 26 quarters since.
- Group One Trading's Neurocrine Biosciences position peaked at $4.83M in Q1 2022.
- 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.